vs
FIRST BANCORP（FBNC）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
FIRST BANCORP的季度营收约是RIGEL PHARMACEUTICALS INC的1.3倍（$89.6M vs $69.8M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs 22.7%，领先361.3%），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs -7.3%）
第一银行控股（First Bancorp）是总部位于美国北卡罗来纳州南派恩斯的银行控股集团，旗下第一银行业务覆盖北卡罗来纳州与南卡罗来纳州两大区域，为当地客户提供各类银行金融服务。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
FBNC vs RIGL — 直观对比
营收规模更大
FBNC
是对方的1.3倍
$69.8M
营收增速更快
RIGL
高出28.4%
-7.3%
净利率更高
RIGL
高出361.3%
22.7%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $89.6M | $69.8M |
| 净利润 | $20.4M | $268.1M |
| 毛利率 | — | 91.5% |
| 营业利润率 | 29.0% | 33.2% |
| 净利率 | 22.7% | 384.0% |
| 营收同比 | -7.3% | 21.2% |
| 净利润同比 | 9.0% | 1769.2% |
| 每股收益（稀释后） | $0.49 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FBNCRIGL
| Q4 25 | — | $69.8M | ||
| Q3 25 | $89.6M | $69.5M | ||
| Q2 25 | $111.0M | $101.7M | ||
| Q1 25 | $105.8M | $53.3M | ||
| Q4 24 | — | $57.6M | ||
| Q3 24 | $96.6M | $55.3M | ||
| Q2 24 | $95.7M | $36.8M | ||
| Q1 24 | $92.2M | $29.5M |
净利润FBNCRIGL
| Q4 25 | — | $268.1M | ||
| Q3 25 | $20.4M | $27.9M | ||
| Q2 25 | $38.6M | $59.6M | ||
| Q1 25 | $36.4M | $11.4M | ||
| Q4 24 | — | $14.3M | ||
| Q3 24 | $18.7M | $12.4M | ||
| Q2 24 | $28.7M | $-1.0M | ||
| Q1 24 | $25.3M | $-8.2M |
毛利率FBNCRIGL
| Q4 25 | — | 91.5% | ||
| Q3 25 | — | 93.2% | ||
| Q2 25 | — | 95.6% | ||
| Q1 25 | — | 91.7% | ||
| Q4 24 | — | 89.9% | ||
| Q3 24 | — | 85.5% | ||
| Q2 24 | — | 92.4% | ||
| Q1 24 | — | 93.1% |
营业利润率FBNCRIGL
| Q4 25 | — | 33.2% | ||
| Q3 25 | 29.0% | 40.9% | ||
| Q2 25 | 44.9% | 60.1% | ||
| Q1 25 | 44.2% | 23.9% | ||
| Q4 24 | — | 28.9% | ||
| Q3 24 | 23.4% | 25.4% | ||
| Q2 24 | 38.5% | 1.2% | ||
| Q1 24 | 34.5% | -23.6% |
净利率FBNCRIGL
| Q4 25 | — | 384.0% | ||
| Q3 25 | 22.7% | 40.2% | ||
| Q2 25 | 34.7% | 58.6% | ||
| Q1 25 | 34.4% | 21.5% | ||
| Q4 24 | — | 24.9% | ||
| Q3 24 | 19.3% | 22.5% | ||
| Q2 24 | 30.0% | -2.8% | ||
| Q1 24 | 27.4% | -27.9% |
每股收益（稀释后）FBNCRIGL
| Q4 25 | — | $14.11 | ||
| Q3 25 | $0.49 | $1.46 | ||
| Q2 25 | $0.93 | $3.28 | ||
| Q1 25 | $0.88 | $0.63 | ||
| Q4 24 | — | $0.82 | ||
| Q3 24 | $0.45 | $0.70 | ||
| Q2 24 | $0.70 | $-0.06 | ||
| Q1 24 | $0.61 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $155.0M |
| 总债务越低越好 | $92.4M | $52.5M |
| 股东权益账面价值 | $1.6B | $391.5M |
| 总资产 | $12.8B | $513.6M |
| 负债/权益比越低杠杆越低 | 0.06× | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资FBNCRIGL
| Q4 25 | — | $155.0M | ||
| Q3 25 | — | $137.1M | ||
| Q2 25 | — | $108.4M | ||
| Q1 25 | — | $77.1M | ||
| Q4 24 | — | $77.3M | ||
| Q3 24 | — | $61.1M | ||
| Q2 24 | — | $49.1M | ||
| Q1 24 | — | $49.5M |
总债务FBNCRIGL
| Q4 25 | — | $52.5M | ||
| Q3 25 | $92.4M | $60.0M | ||
| Q2 25 | $92.2M | $60.0M | ||
| Q1 25 | $92.1M | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | $91.7M | $60.0M | ||
| Q2 24 | $91.5M | $60.0M | ||
| Q1 24 | $332.3M | $60.0M |
股东权益FBNCRIGL
| Q4 25 | — | $391.5M | ||
| Q3 25 | $1.6B | $117.6M | ||
| Q2 25 | $1.6B | $81.9M | ||
| Q1 25 | $1.5B | $18.6M | ||
| Q4 24 | — | $3.3M | ||
| Q3 24 | $1.5B | $-14.6M | ||
| Q2 24 | $1.4B | $-29.9M | ||
| Q1 24 | $1.4B | $-31.7M |
总资产FBNCRIGL
| Q4 25 | — | $513.6M | ||
| Q3 25 | $12.8B | $242.5M | ||
| Q2 25 | $12.6B | $206.7M | ||
| Q1 25 | $12.4B | $176.0M | ||
| Q4 24 | — | $164.0M | ||
| Q3 24 | $12.2B | $139.4M | ||
| Q2 24 | $12.1B | $128.4M | ||
| Q1 24 | $12.1B | $126.5M |
负债/权益比FBNCRIGL
| Q4 25 | — | 0.13× | ||
| Q3 25 | 0.06× | 0.51× | ||
| Q2 25 | 0.06× | 0.73× | ||
| Q1 25 | 0.06× | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | 0.06× | — | ||
| Q2 24 | 0.07× | — | ||
| Q1 24 | 0.24× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $49.7M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $48.2M | — |
| 自由现金流率自由现金流/营收 | 53.8% | — |
| 资本支出强度资本支出/营收 | 1.6% | — |
| 现金转化率经营现金流/净利润 | 2.44× | 0.08× |
| 过去12个月自由现金流最近4个季度 | $182.9M | — |
8季度趋势，按日历期对齐
经营现金流FBNCRIGL
| Q4 25 | — | $22.0M | ||
| Q3 25 | $49.7M | $24.0M | ||
| Q2 25 | $45.7M | $30.5M | ||
| Q1 25 | $52.6M | $-893.0K | ||
| Q4 24 | — | $14.5M | ||
| Q3 24 | $38.4M | $21.7M | ||
| Q2 24 | $87.7M | $302.0K | ||
| Q1 24 | $-20.1M | $-5.0M |
自由现金流FBNCRIGL
| Q4 25 | — | — | ||
| Q3 25 | $48.2M | — | ||
| Q2 25 | $44.3M | — | ||
| Q1 25 | $52.4M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $38.0M | — | ||
| Q2 24 | $87.6M | — | ||
| Q1 24 | $-21.7M | — |
自由现金流率FBNCRIGL
| Q4 25 | — | — | ||
| Q3 25 | 53.8% | — | ||
| Q2 25 | 39.9% | — | ||
| Q1 25 | 49.5% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 39.3% | — | ||
| Q2 24 | 91.6% | — | ||
| Q1 24 | -23.6% | — |
资本支出强度FBNCRIGL
| Q4 25 | — | — | ||
| Q3 25 | 1.6% | — | ||
| Q2 25 | 1.2% | — | ||
| Q1 25 | 0.2% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.5% | — | ||
| Q2 24 | 0.1% | — | ||
| Q1 24 | 1.8% | — |
现金转化率FBNCRIGL
| Q4 25 | — | 0.08× | ||
| Q3 25 | 2.44× | 0.86× | ||
| Q2 25 | 1.19× | 0.51× | ||
| Q1 25 | 1.44× | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | 2.06× | 1.75× | ||
| Q2 24 | 3.06× | — | ||
| Q1 24 | -0.80× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
